Profound Medical Announces U.S. FDA 510(k) Clearance for TULSA-PRO®

Ontario Industry Updates
Written By Guest User

Profound Medical announced that they have received 510(k) clearance from the U.S. Food and Drug Administration to market TULSA-PRO® for ablation of prostate tissue.

Click here to learn more

Guest User
Previous

iMerciv Accepted into CTA Silicon Valley Fall 2019 Cohort
Next

Reviewing 'In-Licensing from Tech Transfer Offices: Terms, Tips & Impact on Investability'